Covalon Technologies Ltd. (CVALF) Financials

CVALF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 25.8 million 3.5 million
March 31, 2026 23.9 million 3.7 million
Dec. 31, 2025 23.9 million 4.7 million
Sept. 30, 2025 25.9 million 3.9 million

CVALF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 1.8 million ?
March 31, 2026 -952107 51187
Dec. 31, 2025 3.7 million 49256
Sept. 30, 2025 -402829 45700

CVALF Net Income

No data available :(

CVALF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 13.7 million - 948486
March 31, 2026 11.9 million - 1.3 million
Dec. 31, 2025 13.0 million 1.1 million 1.5 million
Sept. 30, 2025 12.5 million 1.2 million 1.6 million

CVALF Shares Outstanding

No data available :(

CVALF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 207321 - 2.5 million 717660
March 31, 2026 124211 225931 2.9 million -
Dec. 31, 2025 475582 193174 2.6 million -
Sept. 30, 2025 58783 226089 2.4 million 841242

CVALF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 7.1 million 2.5 million
March 31, 2026 6.3 million 2.6 million
Dec. 31, 2025 5.0 million 2.2 million
Sept. 30, 2025 6.2 million 3.0 million

CVALF

Price: $2.70

52 week price:
1.16
3.20

Dividend Yield: 4.45%

Earnings Per Share: 0.05 USD

P/E Ratio: 27.60

Exchange: OQX

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 66.0 million

Links: